Case Control Study
Copyright ©The Author(s) 2022.
World J Diabetes. Aug 15, 2022; 13(8): 643-653
Published online Aug 15, 2022. doi: 10.4239/wjd.v13.i8.643
Table 2 Baseline characteristics
Control, n = 908HTN, n = 1061HTN with T2DM, n = 683
P value
Control vs HTN
Control vs HTN + T2DM
HTN vs HTN + T2DM
EthnicHan455406486< 0.0001< 0.0001< 0.0001
Mongolian453655197
GenderMale357601397< 0.0001< 0.00010.542
Female551460286
Age48.11 ± 15.0654.49 ± 15.6763.89 ± 11.17< 0.0001< 0.0001< 0.0001
Weight (kg)66.14 ± 11.0672.32 ± 12.0673.35 ± 12.48< 0.0001< 0.00010.2156
Height (cm)163 ± 0.09168 ± 0.08161.26 ± 0.10< 0.00010.61100.0032
BMI (kg/m2)25.27 ± 8.5025.56 ± 3.6326.48 ± 5.120.40670.75880.8723
FBS (mmol/L)5.06 ± 0.495.73 ± 0.778.59 ± 3.370.0721< 0.0001< 0.0001
SBP (mm Hg)117.21 ± 14.27151.10 ± 18.94166.47 ± 17.53< 0.0001< 0.0001< 0.0001
DBP (mm Hg)77.20 ± 7.9588.59 ± 12.74100.84 ± 13.31< 0.0001< 0.0001< 0.0001
TG (mmol/L)1.63 ± 1.062.24 ± 1.522.59 ± 12.140.06260.00510.4768
CHO (mmol/L)4.53 ± 1.304.47 ± 3.594.52 ± 1.260.89130.99840.8885
HDL (mmol/L)1.44 ± 0.541.75 ± 0.951.27 ± 0.35< 0.0001< 0.0001< 0.0001
LDL (mmol/L)2.84 ± 1.002.87 ± 1.382.94 ± 11.10.99210.92250.9586